Research Institute for Science & Technology, Tokyo University of Science

Development of Superior Cell and DDS for Regenerative Medicine

Japanese

Development of superior cells and DDS for accelerating regenerative medicine

Cell-based therapy can be greatly accelerated by applying the concept of drug delivery system (DDS), i.e., drug delivery at the right time, at the right site of action, and in the right amount, to cells that are administered for disease treatment. This division aims at developing “superior cells” whose functions are extremely upregulated and DDS that improves their functions.

contacts
Research Institute for Science & Technology, Tokyo University of Science

Development of Superior Cell and DDS for Regenerative Medicine

Phone:04-7124-1501(ext)6451
email:kusamori@rs.tus.ac.jp

News & topics
  • Jun 20, 2022. The home page of the Division was launched.